Latest Earnings Results: Q2 '26
Estimated EPS
$2.94
Reported EPS
$3.60
Surprise
+22.49%
Estimated Rev
$2.46B
Reported Rev
$2.74B
Surprise
+11.2%
$BIIB Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.66 down -84.76% YoY • Reported revenue of $2.74B up 3.42% YoY • Biogen expects full year 2026 Non-GAAP diluted EPS of $12.00 to $13.00, while total revenue is projected to increase by a mid-single digit percentage compared to 2025 for Biogen.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $2.03 | -- | -- | N/A |
Q2 '26 | $2.94 | $3.60 | 22.49% | BEAT |
Q1 '26 | $3.08 | $3.57 | 15.77% | BEAT |
Q4 '25 | $1.63 | $1.99 | 22.45% | BEAT |
Q3 '25 | $3.88 | $4.81 | 23.89% | BEAT |